Small molecule compound
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TECHNODERMA MEDICINES
- Publication Date
- 2020-03-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of small molecule compounds, in particular to a small molecule compound and its derivatives that can be used to treat, prevent and alleviate autoimmune diseases and or immune-related inflammatory skin diseases. Background technique
[0002] The JAK (Janus Kinase)-STAT (Signal Transducer and Activator of Transcription proteins) signal transduction pathway is the main pathway for the intracellular transduction of signals stimulated by the combination of inflammatory cytokines and receptors. JAKs is a family of intracellular non-receptor tyrosine kinases (Tyrosine Kinase), including four members JAK1, JAK2, JAK3 and tyrosine kinase 2 (TYK2). JAKs are mainly expressed in hematopoietic cells, leukocytes and intestinal epithelial cells, and are responsible for mediating the signal transmission of various cytokines involved in inflammatory responses. When cytokines bind to cell surface receptors, JAKs are activated ...